bpc 157 peptide purchase BPC-157 Therapy Beverly Hills BPC-157 CAPS/VIAL SET - Research

The molecule was advanced into clinical development by the Croatian pharmaceutical company Pliva under the designations PL-10, PLD-116, and PL 14736 for inflammatory bowel disease research

Gastrointestinal and Cytoprotective Investigations Given its origin as a fragment of a gastric peptide, it is no surprise that BPC-157's effects on the GI tract have been extensively studied

B12 shots for malabsorption or dietary restriction Vegans, vegetarians, older adults, and people with GI conditions (Crohn's disease, celiac disease, pernicious anemia) commonly have inadequate B12 absorption

It is specifically formulated for use in diluting or dissolving medications forinjection or research applicationsthat require a sterile solution